Clinical Trial Update: Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the safety and tolerability of intravenous VIT-45 in patients with iron deficiency anemia, with the study completed and results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• VIT-45

Snippet

Sponsor: American Regent, Inc. | Conditions: Anemia | Phase 3 | Status: COMPLETED | Results posted: 2025-04-18